Evercore ISI Group Maintains In-Line on Teladoc Health, Lowers Price Target to $7.5

Benzinga Newsdesk www.benzinga.com Negative 54.4%

Neg 54.4% Neu 0% Pos 0%

Evercore ISI Group analyst Elizabeth Anderson maintains Teladoc Health (NYSE:TDOC) with a In-Line and lowers the price target from $10 to $7.5.